noted an increase in MUC1 expression across various tumors, enhanced by heregulin, which positions its C-terminal subunit in mitochondria, thereby inhibiting cisplatin-induced apoptotic signaling and reducing tumor cell sensitivity to chemotherapy drugs (21). This evidence concerns the gene MUC1 and neoplasm.